These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


195 related items for PubMed ID: 23539872

  • 1. [Nasal decongestants and eye drops: keep out of children's reach!].
    Poulin-Chartrand S.
    Perspect Infirm; 2013; 10(2):63. PubMed ID: 23539872
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Rhinitis medicamentosa, an increasing problem. Do nose drops adversely affect bacterial infections?].
    Wilhelmson B.
    Lakartidningen; 1994 Dec 07; 91(49):4635-6. PubMed ID: 7808178
    [No Abstract] [Full Text] [Related]

  • 6. Reversible cardiomyopathy due to chronic use of xylometazoline topical nasal spray.
    Figueiras-Graillet LM, Martínez-Sellés M, Perez-David E, Fernandez-Avilés F.
    Int J Cardiol; 2013 Apr 05; 164(2):e17-8. PubMed ID: 23079093
    [No Abstract] [Full Text] [Related]

  • 7. [Mobitz I after accidental ingestion of eyedrops].
    Martínez-Albaladejo M, Alcázar-Gambín J, Melgares de Aguilar Y Mata JM, García-Navarro J.
    An Med Interna; 1996 Jul 05; 13(7):359-60. PubMed ID: 8962991
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Safety and toleration of oxymetazoline ophthalmic solution.
    Samson CR, Danzig MR, Sasovetz D, Thompson HS.
    Pharmatherapeutica; 1980 Jul 05; 2(6):347-52. PubMed ID: 7433475
    [Abstract] [Full Text] [Related]

  • 10. Acute and chronic conjunctivitis due to over-the-counter ophthalmic decongestants.
    Soparkar CN, Wilhelmus KR, Koch DD, Wallace GW, Jones DB.
    Arch Ophthalmol; 1997 Jan 05; 115(1):34-8. PubMed ID: 9006422
    [Abstract] [Full Text] [Related]

  • 11. The "nose drop nose" due to oxymetazoline (Afrin) and other topical vasoconstrictors.
    Feinberg AR, Feinberg SM.
    IMJ Ill Med J; 1971 Jul 05; 140(1):50-2. PubMed ID: 4104967
    [No Abstract] [Full Text] [Related]

  • 12. [From Sweden].
    Tidsskr Nor Laegeforen; 1969 Nov 01; 89(21):1657. PubMed ID: 4097961
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oxymetazoline solutions inhibit middle ear pathogens and are not ototoxic.
    Isaacson G, Buttaro BA, Mazeffa V, Li G, Frenz DA.
    Ann Otol Rhinol Laryngol; 2005 Aug 01; 114(8):645-51. PubMed ID: 16190099
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.